CD274 and neoplasm: Despite high expression of exhaustion markers on B-NHL-derived T-cells, the efficacy of ICB is disappointing, which may not only be explained by a relative low tumor mutational load (see Section 3.1) but also by low expression of inhibitory ligands such as PD-L1 on the tumor cells.